- Home
- PROK vs UPLD Comparison
PROK vs UPLD Comparison
Compare PROK & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- UPLD
- Stock Information
- Founded
- PROK 2015
- UPLD 2010
- Country
- PROK United States
- UPLD United States
- Employees
- PROK N/A
- UPLD N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- UPLD Computer Software: Prepackaged Software
- Sector
- PROK Health Care
- UPLD Technology
- Exchange
- PROK Nasdaq
- UPLD Nasdaq
- Market Cap
- PROK 126.8M
- UPLD 115.3M
- IPO Year
- PROK N/A
- UPLD 2014
- Fundamental
- Price
- PROK $0.84
- UPLD $2.95
- Analyst Decision
- PROK Buy
- UPLD Hold
- Analyst Count
- PROK 4
- UPLD 3
- Target Price
- PROK $5.00
- UPLD $3.75
- AVG Volume (30 Days)
- PROK 434.6K
- UPLD 189.5K
- Earning Date
- PROK 05-09-2025
- UPLD 03-12-2025
- Dividend Yield
- PROK N/A
- UPLD N/A
- EPS Growth
- PROK N/A
- UPLD N/A
- EPS
- PROK N/A
- UPLD N/A
- Revenue
- PROK $76,000.00
- UPLD $274,794,000.00
- Revenue This Year
- PROK N/A
- UPLD N/A
- Revenue Next Year
- PROK N/A
- UPLD N/A
- P/E Ratio
- PROK N/A
- UPLD N/A
- Revenue Growth
- PROK N/A
- UPLD N/A
- 52 Week Low
- PROK $0.80
- UPLD $1.79
- 52 Week High
- PROK $4.44
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- PROK 29.40
- UPLD 38.97
- Support Level
- PROK $0.87
- UPLD $2.79
- Resistance Level
- PROK $1.00
- UPLD $3.48
- Average True Range (ATR)
- PROK 0.10
- UPLD 0.22
- MACD
- PROK 0.01
- UPLD 0.00
- Stochastic Oscillator
- PROK 14.70
- UPLD 19.28
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.